Nn9931-4492
Research payments
$2,896,880
Through program year 2021, $2,896,880 in research payments was reported against Nn9931-4492, across 2,557 payments, paid by Novo Nordisk AS.
- Paid by
- Novo Nordisk AS
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $746,647 | 266 |
| 2020 | Research | $1,601,394 | 1,256 |
| 2019 | Research | $548,839 | 1,035 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Aasim Sheikh Marietta, GA Named on 337 payments
- Zeid Kayali Rialto, CA Named on 181 payments
- Pankaj Patel South Bend, IN Named on 179 payments
- Manal Abdelmalek Durham, NC Named on 173 payments
- Ziad Younes Germantown, TN Named on 166 payments
- Eric Lawitz San Antonio, TX Named on 123 payments
- Reem Ghalib Arlington, TX Named on 116 payments
- Raymond Rubin Atlanta, GA Named on 109 payments
- Kathleen Corey Boston, MA Named on 105 payments
- Raj Vuppalanchi Indianapolis, IN Named on 105 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.